Scribd Logo
Upload

Welcome to Scribd!

  • 11 views

    2022 009 45 Global Trials Summit INVITE 19

    Uploaded by

    assica
    The document provides an agenda for a two-day virtual conference on global clinical trials taking place on September 23rd and 24th, 2022. The conference will feature multiple plenary sessions and talks on a variety of topics related to ongoing and upcoming cardiovascular, diabetes, kidney disease, obesity, and coronary heart disease clinical trials. Talks will explore areas such as heart failure, cardiomyopathy, diabetes management, lipid targets, obesity treatment, and anticoagulation. The conference aims to bring together leading researchers and clinicians to discuss the latest developments and ongoing research efforts in major areas of clinical trials.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    2022 009 45 Global Trials Summit INVITE 19

    Uploaded by

    assica
    11 views1 page
    The document provides an agenda for a two-day virtual conference on global clinical trials taking place on September 23rd and 24th, 2022. The conference will feature multiple plenary sessions and talks on a variety of topics related to ongoing and upcoming cardiovascular, diabetes, kidney disease, obesity, and coronary heart disease clinical trials. Talks will explore areas such as heart failure, cardiomyopathy, diabetes management, lipid targets, obesity treatment, and anticoagulation. The conference aims to bring together leading researchers and clinicians to discuss the latest developments and ongoing research efforts in major areas of clinical trials.

    Original Description:

    Original Title

    2022_009_45_Global_Trials_Summit_INVITE_19

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    The document provides an agenda for a two-day virtual conference on global clinical trials taking place on September 23rd and 24th, 2022. The conference will feature multiple plenary sessions and talks on a variety of topics related to ongoing and upcoming cardiovascular, diabetes, kidney disease, obesity, and coronary heart disease clinical trials. Talks will explore areas such as heart failure, cardiomyopathy, diabetes management, lipid targets, obesity treatment, and anticoagulation. The conference aims to bring together leading researchers and clinicians to discuss the latest developments and ongoing research efforts in major areas of clinical trials.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    11 views1 page

    2022 009 45 Global Trials Summit INVITE 19

    Uploaded by

    assica
    The document provides an agenda for a two-day virtual conference on global clinical trials taking place on September 23rd and 24th, 2022. The conference will feature multiple plenary sessions and talks on a variety of topics related to ongoing and upcoming cardiovascular, diabetes, kidney disease, obesity, and coronary heart disease clinical trials. Talks will explore areas such as heart failure, cardiomyopathy, diabetes management, lipid targets, obesity treatment, and anticoagulation. The conference aims to bring together leading researchers and clinicians to discuss the latest developments and ongoing research efforts in major areas of clinical trials.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    Virtual Conference

    Global
    Trials summit 2022
    Friday, 23 September 2022 and
    Saturday, 24 September 2022 Register at: www.GlobalTrialsSummit.com
    Friday, 23 September 2022 (all times in BST)
    PLENARY #1 Marianna Fontana, MD, PhD, FRCP
    University College London,
    13:00 Transthyretin Amyloid Cardiomyopathy: London, England, UK
    A model for precision medicine in cardiology
    HEART FAILURE AND CARDIOMYOPATHY TRIALS KIDNEY DISEASE TRIALS
    13:30 h Opening Remarks Dr Shelley Zieroth 16:00 h Opening Remarks Dr Kirsten Johansen
    13:35 h CHIEF-HF and PRESERVED-HF Dr Mikhail Kosiborod 16:05 h EMPA-KIDNEY Update: Trial in context Dr Parminder Judge
    13:45 h EMPEROR-Preserved and EMPULSE Dr Faiez Zannad 16:15 h FIDELITY Programme: Kidney outcomes Dr George Bakris
    14:00 h DELIVER Dr Scott Solomon 16:25 h FIDELITY Programme: CV outcomes Dr Stefan Anker
    14:10 h DIAMOND Dr Javed Butler 16:35 h ASCEND Program Dr Ajay Singh
    14:20 h Q&A 16:45 h HIF prolyl hydroxylase inhibitors: Where do Dr Kirsten Johansen
    14:35 h Break we stand?
    14:45 h EXPLORER-LTE and VALOR-HCM Dr Carolyn Ho 16:55 h Q&A
    14:55 h Other HF and cardiomyopathy headliners Dr Carolyn Lam 17:10 h Break
    15:10 h Putting in together in the guidelines Dr Biykem Bozkurt 17:20 h GLP-1RAs and dual GIP-GLP-1 RAs for kidney Dr Katherine Tuttle
    function preservation
    15:25 h Ongoing trials Dr John McMurray
    15:35 h
    17:35 h Treating comorbidity in CKD : what should we Dr Adeera Levin
    Q&A be doing in 2023?
    15:50 h Closing Remarks Dr Mark Petrie 17:50 h Ongoing trials Dr Hiddo Heerspink
    18:00 h Q&A
    18:15 h Closing Remarks Dr John McMurray

    Saturday, 24 September 2022 (all times in BST)


    PLENARY #2 Paul M Ridker, MD, MPH, FACC, FAHA
    Harvard Medical School,
    13:00 Extinguishing the fire of inflammation in Boston, MA, USA
    cardiovascular diseases
    DIABETES, OBESITY and LIPIDS CORONARY HEART DISEASE AND STROKE TRIALS
    13:30 h Opening Remarks Dr Naveed Sattar 16:05 h Opening Remarks Dr Margaret McEntegart
    13:40 h AMPLITUDE-O Dr Hertzel Gerstein 16:15 h PARADISE-MI – paradise lost or found? Dr Marc Pfeffer
    13:50 h CV risk reduction in T2D in 2022 Dr Subodh Verma 16:25 h REVIVED-BCIS2 Dr Mark Petrie
    14:00 h The STEP Program Dr Melanie Davies 16:35 h SECURE polypill after AMI Dr Valentin Fuster
    14:15 h The SURPASS and SURMOUNT Programmes Dr Stefano Del Prato 16:45 h ADAPTABLE – a new way to do trials? Dr Adrian Hernandez
    14:30 h Q&A 16:55 h Q&A
    14:45 h Break 17:10 h Break
    14:55 h New lipid targets and therapeutic approaches Dr Aruna Pradhan 17:20 h ALL-HEART Dr Isla MacKenzie
    in 2022: ApoC-III, PPARα modulators, Lp(a), 17:30 h TIME Dr Thomas MacDonald
    ANGPTL3, siRNAs and ASOs 17:40 h Anticoagulant news: INVICTUS, AXIOMATIC Dr Stuart Connolly
    15:10 h Putting it all together – managing obesity Dr Rachel Batterham and the PACIFIC trials
    in 2022 17:55 h Ongoing trials Dr Deepak Bhatt
    15:20 h Putting it all together – glycaemic control in Dr Silvio Inzucchi 18:05 h Q&A
    T2D in 2022 18:20 h Closing Remarks Dr Subodh Verma
    15:30 h Ongoing trials Dr Pardeep Jhund
    15:40 h Q&A There is no registration fee to participate in this virtual conference.
    15:55 h Closing Remarks Dr Pardeep Jhund For more information, please email: [email protected]
    This program has been Media partners:
    developed by:

    Sponsors:

    You might also like